Esteve acquires Germany’s Riemser, Cinfa invests €200m over four years, and Spanish self-care association, ANEFP, restarts its successful pharmacy training program.

Behavioral insights can help companies make a success of Rx-to-OTC switches, explains Hamell’s managing director Fiona Hammond, in an exclusive interview with HBW Insight. 

Tom's natural claims on toothpastes and deodorants are false and misleading, a plaintiff alleges in a proposed class action filed in Massachusetts federal court. Similar to previous complaints against Colgate/Tom’s, the plaintiff’s case is premised on the contention that “natural,” as opposed to “100% natural,” means no synthetic ingredients.

The California Assembly Committee on Environmental Safety and Toxic Materials voted yes to proposed AB 495 at a 14 January hearing in Sacramento. As drafted, the bill continues to face industry opposition, but its author and cosponsors have committed to changes that would align the legislation more closely with EU regulations and potentially resolve industry’s biggest concerns.

The International Fragrance Association has given its ingredient safety standards a major overhaul based on a new methodology that accounts for aggregate exposure and an updated Quantitative Risk Assessment model for dermal sensitization.

Minnesota Democrat Collin Peterson’s bill, the first targeting FDA’s CBD question, could provide an entire answer or it could set table for discussion in Congress about legislation on establishing an FDA regulation on using CBD, and potentially other hemp-derived substances, in products other than drugs subject to its oversight.

Colgate rolls out first recyclable toothpaste tube in UK with launch of Smile for Good. Selling now in retailers including Tesco and Morrisons, the line featuring Protection and Whitening versions is the first toothpaste certified by the Vegan Society.

“We ought to deal with this. There are questions on long-term safety and questions on efficacy claims that are just not proven,” says the Maryland Republican. “The biggest threat hanging over, in my mind, the farmers who want to grow hemp, is what if the FDA comes out tomorrow and says, ‘You can't sell any product’? The market collapses,”he said at a CBD policy conference.

During first-ever congressional hearing on federal policies for lawful use of cannabis, House Energy and Commerce Health Subcommittee Chairwoman Anna Eschoo says with $2m appropriated to develop a regulation on CBD’s use in non-drug products during, FDA should deliver.

Minnesota Democrat Collin Peterson’s bill, the first targeting FDA’s CBD question, could provide an entire answer or it could set table for discussion in Congress about legislation on establishing an FDA regulation on using CBD, and potentially other hemp-derived substances, in products other than drugs subject to its oversight.

Behavioral insights can help companies make a success of Rx-to-OTC switches, explains Hamell’s managing director Fiona Hammond, in an exclusive interview with HBW Insight. 

OTC drug, supplement and beauty firms are spreading into digital health devices showcased at the 2020 Consumer Electronics Show as technological advancements help consumers reach health and wellness goals. Colgate debuted a smart toothbrush that detects biofilm build-up while L’Oreal introduced AI-powered skin care.